Literature DB >> 18355188

Suction-curettage with combination of two different cannulae in the treatment of axillary osmidrosis and hyperhidrosis.

W O Kim1, Y Song, H K Kil, K B Yoon, D M Yoon.   

Abstract

OBJECTIVE: To investigate the efficacy and safety of suction-curettage with a combination of two different cannulae for treatment of axillary osmidrosis and hyperhidrosis.
DESIGN: Retrospective analysis of patients who underwent surgery from September 2004 to September 2006.
SETTING: Outpatient clinic for hyperhidrosis at a university-affiliated hospital.
SUBJECTS: Sixty-five patients who were treated for axillary malodor and hyperhidrosis.
INTERVENTIONS: Patients were sequentially treated with Fatemi and Cassio cannulae. MAIN OUTCOME MEASURES: Demographic data, severity data (assessment of malodor), degree of satisfaction, sweating, hair growth, scarring, recurrence and complications.
RESULTS: Sixty of the 65 patients (96.9%) had excellent to fair results, and only 2 patients (3.1%) had poor results. Complications occurred in 4 patients (6.2%). Recurrence occurred in 3 patients (4.6%).
CONCLUSIONS: This simplified and inexpensive method resulted in a high success rate with low complications and high satisfaction with minimal scarring and rapid recovery.

Entities:  

Mesh:

Year:  2008        PMID: 18355188     DOI: 10.1111/j.1468-3083.2008.02717.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  2 in total

Review 1.  Surgical treatment of axillary hyperhidrosis by suction-curettage of sweat glands.

Authors:  Rebeca Maffra de Rezende; Flávio Barbosa Luz
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

2.  The curative effect of liposuction curettage in the treatment of bromhidrosis: A meta-analysis.

Authors:  Lianbo Zhang; Feifei Chen; Jiao Kong; Zhuonan Li; Xiaoqiang Wen; Jun Liu
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.